Generative AI Pushes Big Pharma R&D Beyond Costly Models

The use of OpenAI’s language models, including ChatGPT and Codex, by César de la Fuente’s lab to discover novel antimicrobial peptides marks a pivotal validation of generative AI in early-stage drug discovery. This moves AI from a tool for analysis to one for direct biological creation, fundamentally challenging the high-cost, low-speed R&D models dominant in pharmaceuticals. While DeepMind